For ResearchersBuild Custom Pre-Screening Tools for Vitiligo Studies

For Researchers | Build Custom Pre-Screening Tools for Vitiligo Studies


Finding qualified vitiligo patients can be challenging, especially with no national or international patient registries available. We offer a solution to simplify and accelerate your recruitment process.

Why Work with Us?

  • Unmatched Access: Leverage the largest mailing list in the vitiligo industry for unparalleled reach to potential participants.
  • Custom Pre-Screening Tools: Actively target specific demographics, connect with qualified patients faster, and reduce screening time by up to 50%.

Real-Time Optimization

  • Monitor where patients drop off during pre-screening.
  • Update pre-screener questions instantly—no delays or additional costs.

Key Benefits

  • Time-Saving: Skip manual searches and focus on connecting with participants.
  • Targeted Recruitment: Reach the most relevant candidates for your study.
  • Flexibility: Adapt your strategy on the go to improve outcomes.
  • Cost-Effective: Make updates as needed without extra charges.

By combining our extensive mailing list with customizable, user-friendly pre-screening tools, you can quickly identify and connect with qualified patients, cutting recruitment timelines and enhancing the efficiency of your clinical trial process.

 

FAQOther Questions

  • Does vitiligo increase the risk of skin cancer?

    No, it does not. Despite common misconceptions, people with vitiligo are actually at a lower risk of developing skin cancer—including both nonmelanoma skin cancer (NMSC) and mal...

  • What is the best therapy for localized vitiligo?

    Localized vitiligo, where the white patches are limited to one or a few areas of the body, can be managed with a few treatment approaches. The best therapy usually depends on th...

  • Will it spread?

    Vitiligo's progression and response to treatment can vary significantly among individuals, making it a particularly unpredictable skin condition. Based on the VALIANT study, her...